Content about Diphenhydramine

April 23, 2013

The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

BD Rx, the pharmaceutical arm of the medical technology manufacturer, whose name stands for Becton, Dickinson and Co., received FDA approval for metoclopramide, part of its BD Simplist line of ready-to-administer pre-filled generic injectables. The product is an antiemetic, a drug used to stop vomiting.

April 9, 2013

Cosmederm Bioscience announced that a study recently published in the journal Acta Dermato-Venereologica has established its TriCalm anti-itch product has greater anti-itch efficacy as compared with products containing hydrocortisone or diphenhydramine.

SAN DIEGO — Cosmederm Bioscience last week announced that a study recently published in the journal Acta Dermato-Venereologica has established its TriCalm anti-itch product has greater anti-itch efficacy as compared with products containing hydrocortisone or diphenhydramine.  

March 27, 2013

The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

BD announced the approval of diphenhydramine hydrochloride injection, an antihistamine, packaged in its recently launched Simplist pre-filled injectables, which are made by subsidiary BD Rx and designed to improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence and thus reduce the potential risk of medication errors.

November 29, 2012

While the term homeopathy may remain as foreign to the American consumer as allopathy, more and more shoppers are placing those homeopathic products in their baskets. 


While the term homeopathy may remain as foreign to the American consumer as allopathy, as a relative “class” within each of the respective categories where homeopathic remedies exist, more and more shoppers are placing those homeopathic products in their baskets.

October 10, 2012

AccuDial Pharmaceutical recently launched four products as part of its Go-Green pediatric liquid cough-cold lineup that features dosing information on a rotating label, a larger 6-point font and a dosing cup that's shrink-wrapped to the top of the container.

PALM BEACH GARDENS, Fla. — AccuDial Pharmaceutical recently launched four products as part of its Go-Green pediatric liquid cough-cold lineup that features dosing information on a rotating label, a larger 6-point font and a dosing cup that's shrink-wrapped to the top of the container.

August 20, 2012

UrgentRx will be adding an allergy relief product to its portfolio of on-the-go OTC solutions in October, the company recently announced.

DENVER — UrgentRx will be adding an allergy relief product to its portfolio of on-the-go OTC solutions in October, the company recently announced.

The new product, called Allergy Attack Relief to Go and formulated with 25 mg of diphenhydramine, will be available as a raspberry-flavored powder that will retail for a suggested $1.39.

June 18, 2012

Procter & Gamble on Monday officially announced the introduction of ZzzQuil, a sleep aid addition to its Vicks NyQuil and Vicks DayQuil brands.

CINCINNATI — Procter & Gamble on Monday officially announced the introduction of ZzzQuil, a sleep aid addition to its Vicks NyQuil and Vicks DayQuil brands.

“ZzzQuil not only helps reduce the time it takes for a person to fall asleep, but [also] allows them to sleep soundly so they can wake up rested and refreshed,” stated Dave Tomasi, marketing director of North America for Vicks. “It is a sleep-only solution that delivers effective relief to consumers suffering from occasional sleeplessness.”

March 28, 2011

The U.S. Pharmacopeial Convention last week announced that it is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients. Updated test methodologies are crucial to help counter economically motivated adulteration — in which less expensive and potentially harmful ingredients are substituted for genuine medicines or their ingredients — and also to address the challenge of impurities that may go undetected with older, nonspecific assays and tests.

ROCKVILLE, Md. — The U.S. Pharmacopeial Convention last week announced that it is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients. Updated test methodologies are crucial to help counter economically motivated adulteration — in which less expensive and potentially harmful ingredients are substituted for genuine medicines or their ingredients — and also to address the challenge of impurities that may go undetected with older, nonspecific assays and tests.

November 22, 2010

Johnson & Johnson is recalling millions of packages of OTC drugs for allergies and pain due to manufacturing problems ...

NEW BRUNSWICK, N.J. Johnson & Johnson is recalling millions of packages of over-the-counter drugs for allergies and pain due to manufacturing problems, according to published reports.

The New York Times reported Tuesday that J&J would recall 4 million packages of cherry- and grape-flavored Children’s Benadryl (diphenhydramine) tablets for allergies and 800,000 bottles of children’s Motrin (ibuprofen), a pain drug.